In the article titled “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy” [1], the last sentence in the Abstract should be corrected from “We describe a case of a right-sided metastatic RCC with Level IV thrombus initially managed with Pazopanib followed by Nivolumab and Adalimumab followed by cytoreductive nephrectomy and IVC thrombectomy in the post-targeted therapy setting with complete curative response” to “We describe a case of a right-sided metastatic RCC with Level IV thrombus initially managed with neoadjuvant targeted therapy followed by cytoreductive nephrectomy and IVC thrombectomy in the post-targeted therapy setting with complete curative response”.
References
- 1.Bhat A., Nahar B., Venkatramani V., Banerjee I., Kryvenko O. N., Parekh D. J. Metastatic renal cell carcinoma with level IV thrombus: contemporary management with complete response to neoadjuvant targeted therapy. Case Reports in Urology. 2019;2019:5. doi: 10.1155/2019/7102504.7102504 [DOI] [PMC free article] [PubMed] [Google Scholar]